The FDA has also accepted an abuse-deterrent formulation of oxycodone, containing inactive elements to render the formulation proof against misuse and abuse. This activity comprehensively critiques the indications, system of action, administration, adverse outcomes, and contraindications of oxycodone while highlighting its distinctions from other